2 unknown. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Unknown 2 |
| Phase 1 | 1 | Unknown 1 |
Follow Neoadjuvant Treatment: new trials by email Literature Review of Neoadjuvant Treatment trials Research Report on Neoadjuvant Treatment
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Neoadjuvant Bevacizumab + Chemotherapy Combined With Short-course Radiotherapy Bevacizumab+mFOLFOX6 - Neoadjuvant Treatment, Rectal Cancer | Phase 1 / Phase 2 | Unknown | Shanghai Minimally Invasive Surgery Center | 20 | 2022-11-01 | 2024-03-07 |
| Preoperative Chemoradiotherapy With Cetuximab in Rectal Cancer Cetuximab, Irinotecan, Capecitabine - Rectal Neoplasms, Neoadjuvant Treatment | Phase 2 | Unknown | National Cancer Center, Korea | 40 | 2006-05-01 | 2007-07-25 |
Rectal Neoplasms (2)
Colorectal Neoplasms (2) · Digestive System Diseases (2) · Digestive System Neoplasms (2) · Gastrointestinal Diseases (2) · Gastrointestinal Neoplasms (2) · Intestinal Diseases (2) · Intestinal Neoplasms (2) · Neoplasms (2) · Neoplasms by Site (2) · Rectal Diseases (2)
Capecitabine (1) · Cetuximab (1) · Irinotecan (1)
National Cancer Center, Korea (1) · Shanghai Minimally Invasive Surgery Center (1)
China (1) · South Korea (1)